U S PHYSICAL THERAPY INC /NV
No enriched coverage for $USPH in the last 7 days.
No SEC Form 4 filings for $USPH in the last 30 days.
See all $USPH insider activity →U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. ITEM 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, U.S. Physical Therapy, Inc.(the "Company") entered into a 45-month forward-starting interest rate swap agreement (the “Swap”) with Bank of America, National Association (“Bank of America”) with an initia
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces the Appointment of New Board Member My
Minan Peter Francis purchased 6 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $77.23 ($66.50–$79.00) across 2 trades over 2026-06-12 to 2026-09-11.
Recent USPH coverage spans corporate actions, earnings and financial news.
The swap locks in a fixed rate lower than current SOFR expectations, reducing financing risk.
Board addition may influence governance and strategic direction but no immediate financial impact.
Small insider purchase signals confidence but limited market impact due to low dollar amount.
CFO transition is a near-term governance and execution signal, but the bigger trading driver is the disclosed margin compression, higher debt, and reaffirmed EBITDA range.
Mixed print suggests investors are rewarding revenue resilience while discounting EPS weakness, leaving earnings quality as the key watch item.
AlphAI scores every news story that mentions USPH with an AI model for sentiment and relevance, and aggregates insider trades from U S PHYSICAL THERAPY INC /NV's SEC EDGAR Form 4 filings. Figures refresh continuously.
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. ITEM 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, U.S. Physical Therapy, Inc.(the "Company") entered into a 45-month forward-starting interest rate swap agreement (the “Swap”) with Bank of America, National Association (“Bank of America”) with an initia
1 min readU S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces the Appointment of New Board Member My
1 min readMinan Peter Francis purchased 6 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $77.23 ($66.50–$79.00) across 2 trades over 2026-06-12 to 2026-09-11.
1 min readUS Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.
6 min readThe article highlights Q2 results for outpatient and specialty care firms. Surgery Partners (SGRY) reported slowest revenue growth and weaker full-year guidance, with the stock down 1.4% to $15.32. LifeStance (LFST) revenue rose to $435.4M (+26.1%) and shares rose 18.3% to $12.27. U.S. Physical Therapy (USPH) revenue $214.1M (+8.5%) and shares $81.96. Encompass Health (EHC) revenue $1.60B (+9.6%) and shares $124.69. agilon health (AGL) revenue $1.49B (+7.2%), shares $87.56.
6 min readU S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into and effective as of the 12th day of August, 2026, by and between U. S. Physical Therapy, Inc. a Nevada corporation (“Employer”) and Nchacha Etta (“Employee”). Employer and Employee may be re
4 min readUS Physical Therapy (USPH) discussed its Q2 2026 results and hospital-affiliation rollout. The company said Q2 revenue rose 8.5% to $214M, PT revenue rose 8.4% to $182M, and visits increased 6.6% to 1.662M. Net rate was $107.59. It cited $3.2M higher self-insured health care costs and expects clinic transitions to continue into Q3.
7 min readConestoga Capital Advisors’ Q2 2026 investor letter says small caps strengthened, with the Russell 2000 up and Russell 2000 Growth up 25.7% in Q2. The firm discussed U.S. Physical Therapy (NYSE:USPH), an outpatient clinic operator, and said it sold the position due to labor cost pressures, reimbursement uncertainty, and slower margin growth, despite solid rehab demand. USPH closed at $76.46 on Aug. 6, 2026.
4 min readU S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results, Reaffirms Full Yea
6 min readU.S. Physical Therapy (NYSE: USPH) will report Q2 earnings Wednesday after the bell. The company previously reported $198.3M revenue, up 7.9% YoY, but missed EPS estimates. For the upcoming quarter, analysts expect revenue up 6.4% YoY. The article cites an average analyst price target of $93.67 versus $77.88 and notes peer results from Centene and Tenet.
3 min read
